Health Condition 1: F488- Other specified nonpsychotic mental disorders
Conditions
Interventions
Intervention1: Majoon Brahmi: 5 gm BD with water for 6 weeks.
Control Intervention1: Majoon e Nisyan: 5 gm BD with water for 6 weeks.
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of Zof-e-Dimag wa Hafiza (Cerebro-asthenia) having subjective complaints of cognitive impairment: . Memory loss . Mild headache . speech impairment . writing impairment 2. MMSE score of 10-23 representing mild to moderate cognitive impairment.
Exclusion criteria
Exclusion criteria: 1. Clinical presentation and/or history of any significant organic neurological diseases including space occupying lesions, stroke, head injury, seizure, and mental retardation. 2. Secondary causes of dementia including hypothyroidism or hyperthyroidism. 3. Known cases of B12 vitamin deficiencies. 4. Known case of chronic diseases that requires long-term treatment. 5. Patients on Psychotropic Drugs 6. H/o alcohol or substance abuse or dependence. 7. H/o Hypersensitivity to the study drug or any of its ingredients. 8. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The safety and efficacy of Unani Pharmacopeial formulation Majoon Brahmi in comparison with Majoon e Nisyan in Zof-e-Dimag wa Hafiza (Cerebro-asthenia) will be carried out on the basis of Mini Mental State Examination (MMSE) scoreTimepoint: At Baseline and after every 14 days, (i.e., 0, 14th,28th and 42th day) | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline, at first follow up and at the end of treatment. (i.e., At 0, 14th and 42th day) | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed